AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 MAY 7 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer-A series of research experiments has demonstrated that hepatitis C virus (HCV) DNA vaccine can suppress tumor growth.
The vaccine, developed by researchers at the Karolinska Institute at Huddinge University Hospital in Stockholm, Sweden, contains the genetic components of HCV nonstructural proteins. The gene gun method of delivery appears particularly suited for its administration, researchers report.
"The HCV protease and helicase encompasses the nonstructural (NS)3 protein and the cofactor NS4A, which targets the NS3/4A complex to intracellular membranes," described L. Frelin and coauthors.
Study authors developed expression vectors containing NS3/4A or NS3 only. NS4A augmented the expression of NS3 after transfection, they noted.
"Subsequently, immunization with the NS3/4A gene primed 10- to 100-fold higher levels of NS3-specific antibodies as compared to immunization with the NS3 gene," Frelin's group reported.
The NS3/4A gene also generated an immunoglobulin (Ig)G2a/IgG1 ratio that was more than six times higher than that generated by the NS3 gene. These findings signaled a strong humoral response.
Low dose NS3/4A gene vaccine, delivered intramuscularly, suppressed the ...